by Malabsorption syndrome refers to a group of disorders where the small intestine is unable to absorb some or most nutrients from food. This leads to nutrient deficiencies and malnutrition. The symptoms of malabsorption syndrome include diarrhea, gas, bloating, fatigue, and weight loss. Malabsorption syndrome has various underlying causes such as celiac disease, pancreatic insufficiency, and post-surgery effects. Treatments involve dietary changes, medications, and vitamin/mineral supplements.
The Malabsorption Syndrome Market is estimated to be valued at US$ 3.42 Bn in 2024 and is expected to exhibit a CAGR of 6.8% over the forecast period 2024-2031.
Key Takeaways
Key players: AbbVie Inc. is a leading player focused on developing new drugs for celiac disease and other conditions causing malabsorption syndrome. Immunogen X, LLC is conducting clinical trials for immune modulation therapy in celiac disease.
Key opportunities: Rising incidences of celiac disease worldwide have opened up opportunities for novel treatment options targeting intestinal healing and immunomodulation. Development of affordable generic medications can boost market uptake.
Global expansion: Major players are expanding clinical trials of pipeline drugs across countries to address the global burden. With growing diagnosis rates in Asia Pacific and Latin America, the market sees high potential in emerging regions.
Market drivers: Rising incidences of celiac disease is a major market growth driver. According to statistics, 1 in 100 people worldwide have celiac disease. Increased awareness is leading to improved diagnosis rates. Development of novel treatment modalities also supports market gains.
PEST Analysis
Political: The government policies and regulations will affect the demand of malabsorption syndrome drugs. Governments play a key role in approving new drugs and treatments.
Economic: Global economic conditions influence the spending on healthcare and treatment of chronic diseases like malabsorption syndrome. Recessions may negatively impact the market growth.
Social: Rising awareness about malabsorption syndrome and its treatments is driving more people to seek medical help. An aging population also contributes to the increasing patient pool.
Technological: Advances in drug research and development are expanding treatment options. New diagnostic tools help detect malabsorption syndrome early. Developments in biologics and targeted therapies offer hope of improved outcomes.
The malabsorption syndrome drug market in terms of value is highly concentrated in North America and Europe. The United States and major countries of Europe such as Germany, United Kingdom, France etc. account for over 65% of the global market revenue. This is owing to high healthcare expenditures, availability of advanced treatment facilities and presence of leading pharmaceutical companies in these regions.
Asia Pacific region is poised to be the fastest growing market for malabsorption syndrome drugs during the forecast period. Factors such as rising standards of living, growing medical tourism industry, increasing government focus on healthcare infrastructure will support the market growth in Asia Pacific. Moreover, high population base and rapidly developing economy of China and India provide ample opportunities for market players in the region.
What Are The Key Data Covered In This Malabsorption Syndrome Market Report?
:- Market CAGR throughout the predicted period
:- Comprehensive information on the aspects that will drive the Malabsorption Syndrome Market’s growth between 2024 and 2031.
:- Accurate calculation of the size of the Malabsorption Syndrome Market and its contribution to the market, with emphasis on the parent market
:- Realistic forecasts of future trends and changes in consumer behaviour
:- Malabsorption Syndrome Market Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa
:- A complete examination of the market’s competitive landscape, as well as extensive information on vendors
:- Detailed examination of the factors that will impede the expansion of Malabsorption Syndrome Market vendors
FAQ’s
Q.1 What are the main factors influencing the Malabsorption Syndrome Market?
Q.2 Which companies are the major sources in this industry?
Q.3 What are the market’s opportunities, risks, and general structure?
Q.4 Which of the top Malabsorption Syndrome Market companies compare in terms of sales, revenue, and prices?
Q.5 Which businesses serve as the Malabsorption Syndrome Market’s distributors, traders, and dealers?
Q.6 How are market types and applications and deals, revenue, and value explored?
Q.7 What does a business area’s assessment of agreements, income, and value implicate?
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc.
